EUVIMEDEUVIMED entdecken
Crossref

Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade

Mahdi H Alsugoor, Naif ALSuhaymi, Passant E Moustafa, Mevidette Elmadani, Nehal A Afifi, Ahmed Derzawy, Noha E Ibrahim, Hany M Fayed, Sally A El Awdan

The International Journal of Biochemistry & Cell Biology · 2026

DOI: 10.1016/j.biocel.2026.106964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2026. Verfasst von Mahdi H Alsugoor und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medical Services, Faculty of Health Sciences, Umm Al-Qura University, AlQunfudah, Makkah 21912, Saudi Arabia. Hauptthemen laut MEDLINE: Thiophenes, NF-kappa B, Toll-Like Receptor 4, Glucosides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiophenesNF-kappa BToll-Like Receptor 4GlucosidesTransforming Growth Factor beta1Signal TransductionLiver CirrhosisAnimalsMaleRatsOxidative StressThioacetamideLiverRats, Sprague-Dawley

Stichwörter der Autor:innen

IpragliflozinLiver FibrosisTLR4Thioacetamide

Substanzen

ThiophenesNF-kappa BToll-Like Receptor 4GlucosidesTransforming Growth Factor beta1ipragliflozinThioacetamideTlr4 protein, rat

Autor:innen und Institutionen

  • Department of Emergency Medical Services, Faculty of Health Sciences, Umm Al-Qura University, AlQunfudah, Makkah 21912, Saudi Arabia.
  • Department of Pharmacology, Medical Research and Clinical studies Institute, National Research Centre, Dokki, Giza 12622, Egypt.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Egypt.
  • Deggendorf Institute of Technology, Germany.
  • Microbial Biotechnology Department, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt.
  • Department of Pharmacology, Medical Research and Clinical studies Institute, National Research Centre, Dokki, Giza 12622, Egypt. Electronic address: sallyelawdan@ymail.com.

Zitieren

APA

Alsugoor, M. H., ALSuhaymi, N., Moustafa, P. E., Elmadani, M., Afifi, N. A., Derzawy, A., Ibrahim, N. E., Fayed, H. M., & El Awdan, S. A. (2026). Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade. The International Journal of Biochemistry & Cell Biology. https://doi.org/10.1016/j.biocel.2026.106964

Vancouver

Alsugoor MH, ALSuhaymi N, Moustafa PE, Elmadani M, Afifi NA, Derzawy A, et al. Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade. The International Journal of Biochemistry & Cell Biology. 2026. doi:10.1016/j.biocel.2026.106964

BibTeX
@article{Alsugoor2026,
  author = {Alsugoor, Mahdi H and ALSuhaymi, Naif and Moustafa, Passant E and Elmadani, Mevidette and Afifi, Nehal A and Derzawy, Ahmed and Ibrahim, Noha E and Fayed, Hany M and El Awdan, Sally A},
  title = {Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascade},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2026},
  doi = {10.1016/j.biocel.2026.106964}
}
Kostenlos starten →